By
True North makes partial exit from drug research firm with strong gains
Photo Credit: Satyakam Banerjee/VCCircle

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.It sold a 4.5% stake in Mumbai-listed Syngene ...

TO READ THE FULL STORY


Leave Your Comment(s)